Next Century Growth Investors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-464,589
Closed -$28.9M 129
2023
Q4
$28.9M Sell
464,589
-49,367
-10% -$2.76M 2.81% 9
2023
Q3
$28.8M Buy
513,956
+42,770
+9% +$2.41M 3.14% 6
2023
Q2
$23.8M Buy
471,186
+105,023
+29% +$5.59M 2.29% 16
2023
Q1
$20M Buy
366,163
+23,187
+7% +$1.35M 2.2% 13
2022
Q4
$21.4M Buy
342,976
+7,101
+2% +$471K 2.57% 10
2022
Q3
$23.7M Buy
335,875
+8,249
+3% +$569K 2.89% 9
2022
Q2
$18.6M Buy
327,626
+5,564
+2% +$305K 2.43% 11
2022
Q1
$20.2M Buy
+322,062
New +$17.4M 2.01% 15
2020
Q4
Sell
-387,896
Closed -$19.8M 143
2020
Q3
$19.8M Buy
387,896
+55,630
+17% +$2.32M 2.06% 11
2020
Q2
$11.7M Buy
332,266
+160,322
+93% +$5.52M 1.33% 25
2020
Q1
$4.37M Buy
+171,944
New +$5.11M 0.71% 43

Other funds holding AXNX

Next Century Growth Investors's AXNX Position: Q1 2024 in Review

Next Century Growth Investors sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 464,589 shares — an estimated $28.9M sold.

Next Century Growth Investors first reported a position in AXNX in Q1 2020 and held it in 11 quarters. The position peaked at $28.9M in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Next Century Growth Investors reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Next Century Growth Investors sold 464,589 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $28.9M.
  • Next Century Growth Investors first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Next Century Growth Investors's Axonics, Inc. Common Stock position peaked at $28.9M in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Next Century Growth Investors's 13F filing for Q1 2024, filed 14 May 2024.